As of 2024-12-14, the Fair Value of Novavax Inc (NVAX) is -8.89 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 9.11 USD, the upside of Novavax Inc is -197.60%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -132.70 | -418.30 | -1,743.80 | -657.90 | -545.06 | -699.55 |
| YoY growth | 28.15% | -215.22% | -316.88% | 62.27% | 17.15% | -84.90% |
| Market Cap (mil) | 1,459.24 |
| P/E | |
| Forward P/E |
| EPS | -1.78 |
| Avg earnings growth rate | -84.90% |
| TTM earnings | -284.86 |